By  Brenda Baletti, Ph.D.

The Centers for Disease Control and Prevention on Thursday added the two-shot primary series mRNA COVID-19 vaccine to its routine immunization schedule for children and adults, formalizing the agency’s vaccine advisory committee’s unanimous recommendation made in October 2022.

Although the CDC does not have the authority to set requirements itself, the agency’s immunization schedule provides formal guidance for state and local public health officials who set the rules for which vaccines are required to attend school.

The schedule also is the basis for vaccine recommendations made by most physicians.

[…]

Under the new guidelines, the CDC recommends healthy children 6 months to 11 years old receive a primary series of two doses of the mRNA Moderna or Pfizer-BioNTech monovalent COVID-19 vaccine, followed by a booster of the bivalent shot.

It recommends that healthy people age 12 and older receive two doses of either the Moderna, Pfizer or Novavax vaccine followed by a bivalent booster.

[…]

Data collected by the CDC through its Vaccine Adverse Event Reporting System (VAERS) and a growing number of other sources indicate serious health risks associated with COVID-19 vaccination for children.

“The COVID vaccines have not been shown to be either effective or safe for children,” CHD argued in an amicus brief filed in Louisiana last year. “The benefits to children are minuscule, while the risks — including the risk of potentially fatal heart damage — are ‘known’ and ‘serious,’ as the FDA itself has acknowledged.”

Other changes to the childhood schedule include adding the PVC15 shot, a pneumococcal conjugate vaccine used to help protect against pneumococcal bacteria and only recently approved for children; updated guidance for the flu and hepatitis B vaccines; and new recommendations for the measles, mumps and rubella (MMR) and polio vaccines.

[…]

This would mean the childhood vaccination schedule would increase the number of recommended injections from 54 to 72 over the course of a person’s childhood, between the ages of 6 months and 18 years, The Defender reported last year.

CDC schedule protects pharmaceutical companies from liability for vaccine injuries

Vaccine makers are not liable for injuries or deaths associated with EUA vaccines but can be held liable for injuries caused by a fully licensed vaccine — unless that vaccine is added to the CDC’s childhood vaccination schedule.

Parents of children injured by vaccines listed on the childhood schedule can seek compensation through the taxpayer-funded National Vaccine Injury Compensation Program (NVICP), a no-fault alternative to the traditional legal system for resolving vaccine injury claims.

[…]

Since it was established in 2010, the CICP only compensated 30 of the nearly 12,000 claims filed.

Are we seeing ‘the beginning of the end of Big Pharma’s reign’?

The addition of the COVID-19 vaccine to the immunization schedule “helps ‘normalize’ this vaccine and sends a powerful message to both healthcare providers and the general public that everyone ages 6 months and older should stay up to date with recommended COVID-19 vaccines (including a booster, when eligible), just as they would with any other routinely recommended vaccine,” Dr. Neil Murthy and Dr. A. Patricia Wodi said in a statement reported by CNN.

This “normalization” comes at a time when over 85% of the U.S. population hasn’t been boosted, despite the massive government-sponsored media push.

Nationally, only 12% of children ages 6 months to 4 years have received one dose of the vaccine. Only 58% of children ages 12 to 17 and 32% of children ages 5 to 11 have received two doses of the vaccine. Numbers vary widely across states.

Holland commented on the implications of adding this shot to the schedule:

“The childhood schedule is already unscientific and unjustifiable. Adding this shot may well be the straw that breaks the camel’s back. Parents are likely to resist, finally calling the entire childhood vaccine schedule into question.

“That day has been long in coming, but it is now here. I believe we are now watching the beginning of the end of Big Pharma’s reign over the nation’s children.”

At Wednesday’s congressional hearing, lawmakers repeatedly raised concerns about how regulatory agencies’ flawed recommendations led to a lack of confidence in public institutions.

Rep. Cathy McMorris Rodgers (R-Wash.) said, “There’s serious distrust today with our public health agencies. [Polling indicates] 40% of the public does not trust our public health agencies to handle the next public health emergency.”

Walensky indicated that vaccination rates for all vaccines on the childhood schedule among kindergarten children declined last year, dropping from 95% to 93% over the last two years, amounting to hundreds of thousands of parents opting not to comply with the childhood vaccination schedule.

The most recent VAERS data on vaccine injuries, updated Feb. 2 for children 6 months to 5 years old who received a COVID-19 vaccine, showed reports of 5,737 adverse events, including 244 cases rated as serious and 14 reported deaths.

For 5- to 11-year-olds, there were 16,910 reports of adverse events, including 805 rated as serious and 33 reported deaths.

VAERS is the primary government-funded system for reporting adverse vaccine reactions in the U.S. While reports submitted to VAERS require further investigation before a causal relationship can be confirmed, VAERS historically has been shown to report only 1% of actual vaccine adverse events.

According to Retsef Levi, Ph.D., with the Massachusetts Institute of Technology, the vaccines “cause unprecedented levels of harm, including the death of young people and children.”

Multiple studies have determined that the vaccines increase the risk of myocarditis and pericarditis, particularly in young men.

An October 2022 study revealed the CDC was aware of the safety signal for these side effects months before it informed the public.

At the recent FDA vaccine advisory committee meeting, several committee members also raised concerns about recommending annual bivalent boosters for children given the lack of data.

Dr. Archana Chatterjee, Ph.D., committee member and dean of the Chicago Medical School and vice president for medical affairs at Rosalind Franklin University said:

“As we look at this question [simplifying the vaccination schedule] for young children, the data is just too few for us to really make scientifically sound decisions regarding this question. The trial data need to be much more robust than we have seen in the past.”

In light of data like this, vaccination for COVID-19 for children and healthy people is losing public and even governmental support in some places.

Under public pressure and facing a series of lawsuits, last week California dropped its plan to mandate COVID-19 vaccination for school children.

As of Feb. 6, 21 states have legislation or executive orders banning student vaccine mandates, according to the National Academy for State Health Policy, a nonpartisan organization of state health policymakers.

[…]

Via https://childrenshealthdefense.org/defender/cdc-covid-mrna-vaccine-childhood-schedule/